Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans

Circulation

Volumn 107, Issue 14, 2003, Pages 1877-1883

  De Bruyne, Bernard ^a   Pijls, Nico H J ^c,d   Barbato, Emanuele ^a   Bartunek, Jozef ^a   Bech, Jan Willem ^c   Wijns, William ^a   Heyndrickx, Guy R ^a,b  

^a CARDIOVASCULAR CENTER   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c CATHARINA HOSPITAL   (Netherlands)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Adenosine; Angioplasty; Pressure; Vasodilation

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; CONTRAST MEDIUM; IOHEXOL; PAPAVERINE;

ADULT; AGED; AORTA PRESSURE; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; DOSE RESPONSE; FEMALE; FEMORAL VEIN; HUMAN; HYPEREMIA; MALE; PRIORITY JOURNAL; STEADY STATE; VASCULAR RESISTANCE;

ADENOSINE; ADENOSINE TRIPHOSPHATE; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; IOHEXOL; MALE; MIDDLE AGED; MYOCARDIUM; PAPAVERINE; VASODILATOR AGENTS;

EID: 0344950520     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000061950.24940.88     Document Type: Article

References (18)

1. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87-94.
2. De Bruyne B, Pijls NHJ, Smith L, et al. Coronary thermodilution to assess flow reserve: experimental validation. Circulation. 2001; 104:2003-2006.
3. Pijls NHJ, De Bruyne B, Smith L, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation. 2001;105:2482-2486.
4. Pijls NH, van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354-1367.
5. De Bruyne B, Baudhuin T, Melin Jaet al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 1994;89:1013-1022.
6. Kern MJ, Deligonul U, Tatineni S, et al. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol. 1991;18:718-729.
7. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595-1606.
8. van der Voort PH, van Hagen E, Hendrix G, et al. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn. 1996;39:120-125.
9. Marzilli M, Klassen GA, Maraccini P, et al. Coronary effects of adenosine in conscious man. Eur Heart J. 1989;10F:78-81.
10. Jeremias A, Filardo SD, Withburn RJ, et al. Effects of intravenous and intracoronary adenosine 5′triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation. 2000;101:318-323.
11. Holdright DR, Lindsay DC, Clarcke D, et al. Coronary flow reserve in patients with chest pain and normal coronary arteries. Br Heart J. 1993;70:513-519.
12. De Bruyne B, Hersbach F, Pijls NHJ, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation. 104:2401-2406.
13. Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation. 1985;71:280-288.
14. Yamada H, Azuma A, Hirasaki S, et al. Intracoronary adenosine 5′-triphosphate as an alternative to papaverine for measuring coronary flow reserve. Am J Cardiol. 1994;74:940-941.
15. Miyagawa M, Kumano S, Sekiya M, et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol. 1995;26:1196-1201.
16. Sonoda S, Takeuchi M, Nakashima Y, et al. Safety and optimal dose of intracoronary adenosine 5′-triphosphate for the measurement of coronary flow reserve. Am Heart J. 1998;135:621-627.
17. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation. 2000;102:1233-1238.
18. Gould KL, Coronary Atherosclerosis and Reversing Atherosclerosis. 2nd Ed. London: Arnold Publishers; 1999.